A veteran-led crisis prevention training organization serving communities through both nonprofit and sponsored initiatives. In partnership with KeriCure Medical, we deliver donated advanced wound care solutions and practical, hands-on training to support clinicians, first responders, Department of Defense personnel, and caregivers in real-world settings. Our mission is to equip healthcare professionals, military service members, and caregivers with the tools, confidence, and resources needed to respond effectively in critical moments—whether in hospitals, homes, community environments, or deployment scenarios. By combining education with access to advanced wound care products, we help bridge the gap between preparedness and response, improving outcomes when it matters most. Sozo Coterie Inc. partners with corporate sponsors, foundations, and philanthropic organizations to advance veteran-led community preparedness, training, and resilience initiatives, strengthening the continuum of care across both civilian and military populations. Field Shield® by KeriCure Medical: redefining wound and burn care with a simple, advanced all-in-one solution designed for real world response with application speed, clear protective coverage, clinical confidence and improved patient outcomes from bedside to field .
Reprise Biomedical, Inc.
Reprise Biomedical develops and commercializes novel biologic medical devices that address unmet needs in advanced wound care. Licensed from the University of Minnesota, our proprietary perfusion decellularization technology enables the Miro3D wound matrix, a completely unique 2 cm thick scaffold designed for deep, tunneling, and complex wounds. Unlike flat-sheet competitors, our products provide true three-dimensional solutions that conform to irregular wound geometries and promote tissue regeneration. Product extensions include Miro3D Fibers (particles), MiroTract (matrix on a wire for tunnel delivery), and MiroDry (1 cm matrix), expanding our portfolio to meet a broad range of clinical applications.
NeXtGen Biologics Inc.
NeXtGenTM Biologics Inc. is a medical device company which owns a suite of patents encompassing extracellular matrix (ECM) platform technology derived from the Axolotl, an amphibian known for its regenerative properties. Leveraging a world-class team with expertise in medical devices and breakthrough tissue technologies, the company expects to offer physicians advanced platform solutions designed to treat and manage a myriad of complex conditions seen in wounds, general surgery, trauma, plastic surgery, cardiovascular diseases, neurosurgery, orthopedics and ophthalmology.
NATROX® Wound Care
NATROX® Wound Care leads the way in advanced therapies, sparked by one person’s mission to improve the quality of life for a loved one suffering from a non-healing wound. Its flagship product, NATROX® O2, offers a discreet, wearable device that delivers the natural properties of topical oxygen, empowering patients in their wound-healing journey. Evolving from this vision, we offer innovative med-tech solutions to support clinicians worldwide in effectively managing a variety of chronic wounds.
Medaxis
At Medaxis we are defining the future of wound therapy. Leveraging our 60+ years of expertise in medical vacuum technology, our systems prepare the wound bed for healing and create an optimal wound healing environment. Our intuitive solutions can stand alone and work in combination therapy to advance wound healing. We are eliminating burdensome processes, simplifying the continuity of care and ushering in a new paradigm in wound therapy.
Histologics, LLC
Central to Histologics’ innovation is Kylon®, a patented medical fabric with nylon hooks that collect and trap tissue during transepithelial biopsy procedures. This design reduces contamination risk, ensures complete sample delivery to the lab, and enhances clinician and patient safety. The company’s multi-patented product line—including SoftBiopsy®, Soft K-Cot®, Soft K-Rette®, and SoftBiopsy®+D—is widely used by physicians across the U.S. These tools simplify tissue collection and improve diagnostic accuracy while supporting a better care experience. Histologics continues to expand its impact in both gynecologic and wound care settings, backed by a growing portfolio of U.S. and international patents. Ongoing clinical trials and device evaluations reflect the company’s commitment to quality, efficacy, and life-saving innovation. Histologics’ mission is to improve patient outcomes worldwide by modernizing tissue sampling and supporting clinicians with smarter, safer, more compassionate tool.
DARCO International, Inc.
DARCO International has been a trusted leader in foot and ankle care for over 40 years, specializing in innovative solutions across three distinct lines: diabetic foot & wound care, surgical & trauma recovery, and pain management. Visit us at Booth 1332 to explore our latest innovations in wound care, including the POGO® Athletic Offloading Sneaker, DUOPro™ Wound Care Shoe, Body Armor® PFA Walker, Heel Reliever, and the AllRound Shoe™—designed to support better outcomes and keep patients moving.
Advanced Oxygen Therapy Inc.
AOTI offers the only multi-modality topical wound oxygen (TWO2) therapy proven in both randomized controlled trials and real-world evidence studies to significantly reduce hospitalizations and amputations. Using a combination of non-contact cyclical compression, humidification and high-pressure delivery of oxygen to the wound, TWO2 therapy is proven to result in more effective and durable healing. It can be administered in any clinical setting or self-administered at home, overcoming common barriers to access and compliance, thus helping to advance health equity, improve outcomes and reduce costs. Our NEXA NPWT System combines the simplicity of disposable NPWT with performance features of traditional durable NPWT technology platforms. The NEXA System is a multi-week, multi-patient, disposable NPWT device that offers clinically effective, easy to use, portable and affordable wound care.